| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
|
Golder, Su
|
|
|
|
2 |
p. 167-179
|
artikel
|
| 2 |
A Comparison of the Reliability of Smartphone Apps for Opioid Conversion
|
Haffey, Faye
|
|
2013
|
|
2 |
p. 111-117
|
artikel
|
| 3 |
Active Surveillance of Follow-on Biologics: A Prescription for Uptake
|
Sarpatwari, Ameet
|
|
2016
|
|
2 |
p. 105-108
|
artikel
|
| 4 |
A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry
|
Hachem, Yasmina
|
|
|
|
2 |
p. 161-171
|
artikel
|
| 5 |
Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial
|
Defer, Gilles
|
|
|
|
2 |
p. 223-233
|
artikel
|
| 6 |
Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports
|
Njuguna, Christine
|
|
2015
|
|
2 |
p. 159-169
|
artikel
|
| 7 |
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population
|
Peckham, Alyssa M.
|
|
2017
|
|
2 |
p. 213-228
|
artikel
|
| 8 |
An Evaluation of the THIN Database in the OMOP Common Data Model for Active Drug Safety Surveillance
|
Zhou, Xiaofeng
|
|
2012
|
|
2 |
p. 119-134
|
artikel
|
| 9 |
A New President’s Vision for International Pharmacovigilance
|
Harrison-Woolrych, Mira
|
|
|
|
2 |
p. 79-81
|
artikel
|
| 10 |
Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies
|
Barbui, Corrado
|
|
2013
|
|
2 |
p. 79-90
|
artikel
|
| 11 |
Antipsychotic-Induced Hyponatraemia
|
Meulendijks, Didier
|
|
2010
|
|
2 |
p. 101-114
|
artikel
|
| 12 |
A Post-Authorization Safety Study of Quetiapine as Antidepressant Treatment in Sweden: Nested Case–Control Analyses of Select Outcomes
|
Reutfors, Johan
|
|
|
|
2 |
p. 135-145
|
artikel
|
| 13 |
Appeal for Increasing the Impact of Pharmacovigilance
|
Kant, Agnes C.
|
|
|
|
2 |
p. 113-116
|
artikel
|
| 14 |
Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many
|
Cadogan, Cathal A.
|
|
2015
|
|
2 |
p. 109-116
|
artikel
|
| 15 |
A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation
|
Cahill, Kate
|
|
2009
|
|
2 |
p. 119-135
|
artikel
|
| 16 |
A Risk-Benefit Evaluation of Aciclovir for the Treatment and Prophylaxis of Herpes Simplex Virus Infections
|
Leflore, Stephani
|
|
|
|
2 |
p. 131-142
|
artikel
|
| 17 |
Artificial Intelligence, Real-World Automation and the Safety of Medicines
|
Bate, Andrew
|
|
|
|
2 |
p. 125-132
|
artikel
|
| 18 |
Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
|
Suzuki, Ayako
|
|
|
|
2 |
p. 129-143
|
artikel
|
| 19 |
A Strategy for Regulatory Action When New Adverse Effects of a Licensed Product Emerge
|
Aronson, Jeffrey K.
|
|
2009
|
|
2 |
p. 91-98
|
artikel
|
| 20 |
Author’s Reply to Borg et al. Comment on: “EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars”
|
Calvo, Begoña
|
|
2013
|
|
2 |
p. 125-126
|
artikel
|
| 21 |
Authors’ Reply to Jouanjus and Colleagues’ Comment on “Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter”
|
Sarker, Abeed
|
|
2017
|
|
2 |
p. 187-188
|
artikel
|
| 22 |
Authors’ Reply to Uysal and Colleagues’ Comment on: “Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis”
|
Wong, Adrian
|
|
|
|
2 |
p. 195-196
|
artikel
|
| 23 |
Benefit-Risk Assessment of Dronedarone in the Treatment of Atrial Fibrillation
|
Adlan, Ahmed M. A.
|
|
2012
|
|
2 |
p. 93-110
|
artikel
|
| 24 |
Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
|
Gallwitz, Baptist
|
|
2010
|
|
2 |
p. 87-100
|
artikel
|
| 25 |
β-Blockers and the Risk of Depression: A Matched Case–Control Study
|
Bornand, Delia
|
|
|
|
2 |
p. 181-189
|
artikel
|
| 26 |
Bone Fractures with Sodium-Glucose Co-transporter-2 Inhibitors: How Real is the Risk?
|
Mannucci, Edoardo
|
|
2016
|
|
2 |
p. 115-119
|
artikel
|
| 27 |
Can Angiotensin Receptor Antagonists Be Used Safely in Patients with Previous ACE Inhibitor-Induced Angioedema?
|
Howes, Laurence G.
|
|
|
|
2 |
p. 73-76
|
artikel
|
| 28 |
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
|
Tamargo, Juan
|
|
2015
|
|
2 |
p. 129-152
|
artikel
|
| 29 |
Cancer Chemotherapy-Induced Sinus Bradycardia: A Narrative Review of a Forgotten Adverse Effect of Cardiotoxicity
|
Tamargo, Juan
|
|
|
|
2 |
p. 101-126
|
artikel
|
| 30 |
Comment On: “EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars”
|
Borg, John Joseph
|
|
2013
|
|
2 |
p. 123-124
|
artikel
|
| 31 |
Comment on “Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-analysis”
|
Uysal, Nusret
|
|
|
|
2 |
p. 193
|
artikel
|
| 32 |
Comment on “Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-analysis”
|
Uysal, Nusret
|
|
|
|
2 |
p. 193
|
artikel
|
| 33 |
Comment on ’Prevalence, Incidence and Nature of Prescribing Errors in Hospital Inpatients: A Systematic Review’
|
Franklin, Bryony Dean
|
|
2010
|
|
2 |
p. 163-165
|
artikel
|
| 34 |
Comment on: "Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter"
|
Jouanjus, Emilie
|
|
2017
|
|
2 |
p. 183-185
|
artikel
|
| 35 |
Comparative Tolerability of Sedative Agents in Head-Injured Adults
|
Urwin, Susan C.
|
|
|
|
2 |
p. 107-133
|
artikel
|
| 36 |
Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as Tools for Postmarketing Teratogen Surveillance
|
Charlton, Rachel A.
|
|
2011
|
|
2 |
p. 157-171
|
artikel
|
| 37 |
Compliance with Prescribing and Dispensing Conditions for Valproate and Related Substances in Girls and Women of Childbearing Potential: A Survey of Community Pharmacists in France
|
Fauvelle, Khristina
|
|
|
|
2 |
p. 121-128
|
artikel
|
| 38 |
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis
|
Treem, William R.
|
|
|
|
2 |
p. 133-165
|
artikel
|
| 39 |
Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support
|
Scheife, Richard T.
|
|
2015
|
|
2 |
p. 197-206
|
artikel
|
| 40 |
Consumer Understanding, Preferences, and Responses to Different Versions of Drug Safety Messages in the United States: A Randomized Controlled Trial
|
McCormack, Lauren
|
|
2015
|
|
2 |
p. 171-184
|
artikel
|
| 41 |
Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews
|
Golder, Su
|
|
|
|
2 |
p. 259
|
artikel
|
| 42 |
Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy
|
Day, John W.
|
|
|
|
2 |
p. 191-192
|
artikel
|
| 43 |
Correction to: Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media
|
Micale, Cristina
|
|
|
|
2 |
p. 193
|
artikel
|
| 44 |
Current Understanding of Contrast Media Reactions and Implications for Clinical Management
|
Meth, Marc J.
|
|
|
|
2 |
p. 133-141
|
artikel
|
| 45 |
Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions
|
Hauben, Manfred
|
|
2009
|
|
2 |
p. 99-110
|
artikel
|
| 46 |
Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical Studies
|
Gater, Adam
|
|
|
|
2 |
p. 119-134
|
artikel
|
| 47 |
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes
|
Chomistek, Andrea K.
|
|
|
|
2 |
p. 209-222
|
artikel
|
| 48 |
Drug Form and Expression of Concentration May also Lead to Prescription Errors
|
Mani, Vaithianadan
|
|
2010
|
|
2 |
p. 167-168
|
artikel
|
| 49 |
Drug-Induced Thrombocytopenia
|
Li, Xiaoning
|
|
2007
|
|
2 |
p. 185-186
|
artikel
|
| 50 |
Drug-versus-Drug Adverse Event Rate Comparisons
|
Hochberg, Alan M.
|
|
2009
|
|
2 |
p. 137-146
|
artikel
|
| 51 |
Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study
|
Qin, Simon Xiwen
|
|
|
|
2 |
p. 135-146
|
artikel
|
| 52 |
Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance
|
Kaplan, Sigal
|
|
|
|
2 |
p. 163-177
|
artikel
|
| 53 |
Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial
|
Lopez-Gonzalez, Elena
|
|
2014
|
|
2 |
p. 189-196
|
artikel
|
| 54 |
Effect of Macrolide and Fluoroquinolone Antibacterials on the Risk of Ventricular Arrhythmia and Cardiac Arrest
|
Zambon, Antonella
|
|
2009
|
|
2 |
p. 159-167
|
artikel
|
| 55 |
Effects of Benzodiazepines, Antidepressants and Opioids on Driving
|
Dassanayake, Tharaka
|
|
2011
|
|
2 |
p. 125-156
|
artikel
|
| 56 |
Effects of Proton Pump Inhibitors in Patients Receiving Clopidogrel
|
Oijen, Martijn G. H. van
|
|
2011
|
|
2 |
p. 173
|
artikel
|
| 57 |
Effects of Proton Pump Inhibitors on Platelet Function in Patients Receiving Clopidogrel
|
Kwok, Chun Shing
|
|
2012
|
|
2 |
p. 127-139
|
artikel
|
| 58 |
Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK’s Training and Mentoring Pilot Project in the Abidjan Region
|
Mendoza, Yolanda Guerra
|
|
|
|
2 |
p. 147-159
|
artikel
|
| 59 |
Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety Results
|
Kato, Terufumi
|
|
2017
|
|
2 |
p. 229-237
|
artikel
|
| 60 |
Erratum to: Association Between Statin Use and Bell’s Palsy: A Population-Based Study
|
Hung, Shih-Han
|
|
2017
|
|
2 |
p. 189
|
artikel
|
| 61 |
Erratum to: Principles of signal detection in pharmacovigilance
|
Meyboom, R H B
|
|
1997
|
|
2 |
p. 118
|
artikel
|
| 62 |
Erratum to Trends in hepatic injury associated with unintentional overdose of paracetamol (acetaminophen) in products with and without opioid: an analysis using the National Poison Data System of the American Association of Poison Control Centers, 2000–7
|
Bond, G. R.
|
|
2012
|
|
2 |
p. 158
|
artikel
|
| 63 |
Examining the Tolerability of the Non-Sedating Antihistamine Desloratadine
|
Layton, Deborah
|
|
2009
|
|
2 |
p. 169-179
|
artikel
|
| 64 |
Exposure to Infliximab During Pregnancy: Post-Marketing Experience
|
Geldhof, Anja
|
|
|
|
2 |
p. 147-161
|
artikel
|
| 65 |
Fenofibrate-Induced Hyperhomocysteinaemia
|
Dierkes, Jutta
|
|
|
|
2 |
p. 81-91
|
artikel
|
| 66 |
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources
|
Trifirò, Gianluca
|
|
2017
|
|
2 |
p. 143-149
|
artikel
|
| 67 |
Generating Evidence of Clinical Outcomes of Drug–Drug Interactions
|
Bykov, Katsiaryna
|
|
2017
|
|
2 |
p. 101-103
|
artikel
|
| 68 |
Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study
|
Lantinga, Marten A.
|
|
2016
|
|
2 |
p. 153-167
|
artikel
|
| 69 |
Hepatotoxicity Associated with Long-versus Short-Course HIV-Prophylactic Nevirapine Use
|
McKoy, June M.
|
|
2009
|
|
2 |
p. 147-158
|
artikel
|
| 70 |
Hyperlipidaemia in Paediatric Patients
|
Wierzbicki, Anthony S.
|
|
2010
|
|
2 |
p. 115-125
|
artikel
|
| 71 |
Implementation of a Taxonomy-Based Framework for the Selection of Appropriate Drugs and Outcomes for Real-World Data Signal Detection Studies
|
Coste, Astrid
|
|
|
|
2 |
p. 183-192
|
artikel
|
| 72 |
Incidence of Infusion-Associated Reactions with Rituximab for Treating Multiple Sclerosis
|
Brown, Brandon A.
|
|
2011
|
|
2 |
p. 117-123
|
artikel
|
| 73 |
Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data
|
Meid, Andreas D.
|
|
2016
|
|
2 |
p. 133-144
|
artikel
|
| 74 |
Malaria Prophylaxis in Patients with Renal Impairment
|
Amet, Sabine
|
|
2013
|
|
2 |
p. 83-91
|
artikel
|
| 75 |
Mammalian Target of Rapamycin (mTOR) Inhibitors
|
Sofroniadou, Sofia
|
|
2011
|
|
2 |
p. 97-115
|
artikel
|
| 76 |
Medical Devices: Classification and Analysis of Faults Leading to Harms
|
Ferner, Robin E.
|
|
|
|
2 |
p. 95-102
|
artikel
|
| 77 |
Medical Devices: Definition, Classification, and Regulatory Implications
|
Aronson, Jeffrey K.
|
|
|
|
2 |
p. 83-93
|
artikel
|
| 78 |
Medication Errors Special Interest Group of the International Society of Pharmacovigilance and the Trends in International Collaboration for Patient Safety
|
Elhawary, Mohamed A.
|
|
|
|
2 |
p. 97-99
|
artikel
|
| 79 |
Methods for Assessing the Preventability of Adverse Drug Events
|
Hakkarainen, Katja Marja
|
|
2012
|
|
2 |
p. 105-126
|
artikel
|
| 80 |
Mortality in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study
|
Layton, J. Bradley
|
|
|
|
2 |
p. 195-208
|
artikel
|
| 81 |
Mortality Risk of Hypnotics: Strengths and Limits of Evidence
|
Kripke, Daniel F.
|
|
2015
|
|
2 |
p. 93-107
|
artikel
|
| 82 |
New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019
|
Chan, Felix L.
|
|
|
|
2 |
p. 179-187
|
artikel
|
| 83 |
New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019
|
Chan, Felix L.
|
|
|
|
2 |
p. 179-187
|
artikel
|
| 84 |
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study
|
Babai, Samy
|
|
|
|
2 |
p. 111-117
|
artikel
|
| 85 |
Open-Label Extension Studies
|
Day, Richard O.
|
|
2007
|
|
2 |
p. 93-105
|
artikel
|
| 86 |
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing
|
Dong, Guojun
|
|
|
|
2 |
p. 173-182
|
artikel
|
| 87 |
Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country
|
Nguyen, Khac-Dung
|
|
2017
|
|
2 |
p. 151-159
|
artikel
|
| 88 |
Patient Organizations’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation
|
Chinchilla, Katherine
|
|
|
|
2 |
p. 181-191
|
artikel
|
| 89 |
Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients
|
Schreuder, Nanno
|
|
|
|
2 |
p. 211-222
|
artikel
|
| 90 |
Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems
|
Osokogu, Osemeke U.
|
|
2015
|
|
2 |
p. 207-217
|
artikel
|
| 91 |
Pharmacovigilance and the Null Hypothesis
|
Edwards, I. Ralph
|
|
2011
|
|
2 |
p. 93-96
|
artikel
|
| 92 |
Pharmacovigilance for Children’s Sake
|
Star, Kristina
|
|
2014
|
|
2 |
p. 91-98
|
artikel
|
| 93 |
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
|
Danysh, Heather E.
|
|
|
|
2 |
p. 175-193
|
artikel
|
| 94 |
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
|
Johannes, Catherine B.
|
|
|
|
2 |
p. 157-174
|
artikel
|
| 95 |
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
|
Ekhart, Corine
|
|
|
|
2 |
p. 145-153
|
artikel
|
| 96 |
Post-Transplant Malignancy
|
Penn‡, Israel
|
|
|
|
2 |
p. 101-113
|
artikel
|
| 97 |
Potential Use of Data-Mining Algorithms for the Detection of ‘Surprise’ Adverse Drug Reactions
|
Hauben, Manfred
|
|
2007
|
|
2 |
p. 143-155
|
artikel
|
| 98 |
Preferences of Patients and Pharmacists with Regard to the Management of Drug–Drug Interactions: A Choice-Based Conjoint Analysis
|
Heringa, Mette
|
|
2017
|
|
2 |
p. 179-189
|
artikel
|
| 99 |
Prevention and Pharmacovigilance
|
Edwards, I. Ralph
|
|
2012
|
|
2 |
p. 87-90
|
artikel
|
| 100 |
Propensity Score Weighting Compared to Matching in a Study of Dabigatran and Warfarin
|
Seeger, John D.
|
|
2016
|
|
2 |
p. 169-181
|
artikel
|
| 101 |
Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)
|
Bahri, Priya
|
|
|
|
2 |
p. 193-209
|
artikel
|
| 102 |
Prospective Data Mining of Six Products in the US FDA Adverse Event Reporting System
|
Bailey, Steven
|
|
2010
|
|
2 |
p. 139-146
|
artikel
|
| 103 |
Psychotropic Medications and the Risk of Fracture
|
Takkouche, Bahi
|
|
2007
|
|
2 |
p. 171-184
|
artikel
|
| 104 |
Real-World Data on Nonmedical Use of Tramadol from Patients Evaluated for Substance Abuse Treatment in the NAVIPPRO Addiction Severity Index—Multimedia Version (ASI-MV®) Network
|
Green, Jody L.
|
|
|
|
2 |
p. 235-244
|
artikel
|
| 105 |
Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception
|
Singh, Tina
|
|
|
|
2 |
p. 155-168
|
artikel
|
| 106 |
Risk Evaluation and Mitigation Strategies (REMS)
|
Nicholson, Susan C.
|
|
2012
|
|
2 |
p. 91-104
|
artikel
|
| 107 |
Risk Management of Medicines and Compensation for Harm
|
Ralph Edwards, I.
|
|
2009
|
|
2 |
p. 87-90
|
artikel
|
| 108 |
Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
|
Allen, Katherine C.
|
|
2015
|
|
2 |
p. 183-187
|
artikel
|
| 109 |
Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinson’s Disease and Hyperprolactinaemia
|
Trifirò, Gianluca
|
|
2012
|
|
2 |
p. 159-171
|
artikel
|
| 110 |
Safety and Tolerability of Adoptive Cell Therapy in Cancer
|
Wolf, Benita
|
|
|
|
2 |
p. 315-334
|
artikel
|
| 111 |
Safety and Tolerability of Adoptive Cell Therapy in Cancer
|
Wolf, Benita
|
|
2019
|
|
2 |
p. 315-334
|
artikel
|
| 112 |
Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer
|
Rocco, Danilo
|
|
2019
|
|
2 |
p. 199-209
|
artikel
|
| 113 |
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
|
Procaccio, Letizia
|
|
|
|
2 |
p. 159-179
|
artikel
|
| 114 |
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
|
Procaccio, Letizia
|
|
2019
|
|
2 |
p. 159-179
|
artikel
|
| 115 |
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
|
Wolska-Washer, Anna
|
|
2019
|
|
2 |
p. 295-314
|
artikel
|
| 116 |
Safety and Tolerability of c-MET Inhibitors in Cancer
|
Puccini, Alberto
|
|
2019
|
|
2 |
p. 211-233
|
artikel
|
| 117 |
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
|
Shah, Rashmi R.
|
|
2019
|
|
2 |
p. 181-198
|
artikel
|
| 118 |
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
|
Shah, Rashmi R.
|
|
2019
|
|
2 |
p. 235-245
|
artikel
|
| 119 |
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
|
Baraibar, Iosune
|
|
2019
|
|
2 |
p. 281-294
|
artikel
|
| 120 |
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
|
Baraibar, Iosune
|
|
|
|
2 |
p. 281-294
|
artikel
|
| 121 |
Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology
|
Curigliano, Giuseppe
|
|
2019
|
|
2 |
p. 247-262
|
artikel
|
| 122 |
Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer
|
Carpenter, Richard L.
|
|
2019
|
|
2 |
p. 263-279
|
artikel
|
| 123 |
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre
|
Watson, Sarah
|
|
2017
|
|
2 |
p. 203-212
|
artikel
|
| 124 |
Safety of Antihistamines in Children
|
Ten Eick, Andrew P.
|
|
|
|
2 |
p. 119-147
|
artikel
|
| 125 |
Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
|
Dunne, Michael W.
|
|
2015
|
|
2 |
p. 147-157
|
artikel
|
| 126 |
Safety of Novel Targeted Therapies in Oncology
|
Shah, Rashmi R.
|
|
2019
|
|
2 |
p. 157-158
|
artikel
|
| 127 |
Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study
|
Nigwekar, Prashant V.
|
|
|
|
2 |
p. 171-177
|
artikel
|
| 128 |
Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study
|
Nigwekar, Prashant V.
|
|
2017
|
|
2 |
p. 171-177
|
artikel
|
| 129 |
Safety Profile of Rosuvastatin
|
Kasliwal, Rachna
|
|
2007
|
|
2 |
p. 157-170
|
artikel
|
| 130 |
Safety-Related Regulatory Actions for Orphan Drugs in the US and EU
|
Heemstra, Harald E.
|
|
2010
|
|
2 |
p. 127-137
|
artikel
|
| 131 |
Safety Surveillance of Traditional Chinese Medicine: Current and Future
|
Liu, Shwu-Huey
|
|
2015
|
|
2 |
p. 117-128
|
artikel
|
| 132 |
Selected National Pharmacovigilance Websites
|
Barker, Charlotte I.S.
|
|
2012
|
|
2 |
p. 141-148
|
artikel
|
| 133 |
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19
|
Marzolini, Catia
|
|
|
|
2 |
p. 255-257
|
artikel
|
| 134 |
SGLT2 Inhibitor Use and Risk of Breast Cancer Among Adult Women with Type 2 Diabetes
|
Wang, Fengge
|
|
|
|
2 |
p. 125-133
|
artikel
|
| 135 |
Should Domperidone be Used as a Galactagogue? Possible Safety Implications for Mother and Child
|
Hondeghem, Luc M.
|
|
2016
|
|
2 |
p. 109-113
|
artikel
|
| 136 |
Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network
|
Ferrajolo, Carmen
|
|
2014
|
|
2 |
p. 99-108
|
artikel
|
| 137 |
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
|
Sartori, Daniele
|
|
|
|
2 |
p. 109-120
|
artikel
|
| 138 |
Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration
|
Croteau, David
|
|
|
|
2 |
p. 169-180
|
artikel
|
| 139 |
Specialist Cohort Event Monitoring Studies: A New Study Method for Risk Management in Pharmacovigilance
|
Layton, Deborah
|
|
2015
|
|
2 |
p. 153-163
|
artikel
|
| 140 |
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity
|
Ferner, Robin E.
|
|
|
|
2 |
p. 137-144
|
artikel
|
| 141 |
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
|
Roujeau, Jean-Claude
|
|
2012
|
|
2 |
p. 145-146
|
artikel
|
| 142 |
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs
|
Mazzaglia, Giampiero
|
|
2017
|
|
2 |
p. 191-202
|
artikel
|
| 143 |
Suicidality and Antiepileptic Drugs
|
Kalinin, Vladimir V.
|
|
2007
|
|
2 |
p. 123-142
|
artikel
|
| 144 |
Sumatriptan-Associated Ischemic Colitis: Case report and Review of the Literature and FAERS
|
Nguyen, Thuc Quyen
|
|
2014
|
|
2 |
p. 109-121
|
artikel
|
| 145 |
Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016
|
Moro, Pedro
|
|
2016
|
|
2 |
p. 145-152
|
artikel
|
| 146 |
Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010–May 2016
|
Moro, Pedro
|
|
|
|
2 |
p. 145-152
|
artikel
|
| 147 |
Testosterone Replacement Therapy and Mortality in Older Men
|
Hackett, G. I.
|
|
2015
|
|
2 |
p. 117-130
|
artikel
|
| 148 |
Thalomid® (Thalidomide) Capsules
|
Clark, Todd E.
|
|
|
|
2 |
p. 87-117
|
artikel
|
| 149 |
The Authors’ Reply
|
Lewis, Penny J.
|
|
2010
|
|
2 |
p. 165-166
|
artikel
|
| 150 |
The Authors’ Reply
|
Tully, Mary P.
|
|
2010
|
|
2 |
p. 168-169
|
artikel
|
| 151 |
The Authors’ Reply
|
Loke, Yoon Kong
|
|
2011
|
|
2 |
p. 174
|
artikel
|
| 152 |
The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic
|
Diak, Ida-Lina
|
|
|
|
2 |
p. 145-155
|
artikel
|
| 153 |
The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis
|
Etwel, Fatma
|
|
2016
|
|
2 |
p. 121-132
|
artikel
|
| 154 |
The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine–Naloxone Tablets
|
Hampp, Christian
|
|
|
|
2 |
p. 189-191
|
artikel
|
| 155 |
The Safety of Newer Antidepressants in Pregnancy and Breastfeeding
|
Gentile, Salvatore
|
|
2005
|
|
2 |
p. 137-152
|
artikel
|
| 156 |
The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness
|
Dickinson, Harriet
|
|
|
|
2 |
p. 117-123
|
artikel
|
| 157 |
The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
|
Pradhan, Richeek
|
|
|
|
2 |
p. 103-110
|
artikel
|
| 158 |
Tolerability and Safety of Ropinirole versus Other Dopamine Agonists and Levodopa in the Treatment of Parkinson’s Disease
|
Kulisevsky, Jaime
|
|
2010
|
|
2 |
p. 147-161
|
artikel
|
| 159 |
Tools for Assessing Potential Significance of Pharmacist Interventions: A Systematic Review
|
Vo, Thi-Ha
|
|
2015
|
|
2 |
p. 131-146
|
artikel
|
| 160 |
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
|
Klein, Kevin
|
|
2015
|
|
2 |
p. 185-192
|
artikel
|
| 161 |
Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen)
|
Gulmez, Sinem Ezgi
|
|
2013
|
|
2 |
p. 135-144
|
artikel
|
| 162 |
Treating Hypertension in Older Adults
|
Aronow, Wilbert S.
|
|
2009
|
|
2 |
p. 111-118
|
artikel
|
| 163 |
Treating Severe Malaria in Pregnancy: A Review of the Evidence
|
Kovacs, Stephanie D.
|
|
2015
|
|
2 |
p. 165-181
|
artikel
|
| 164 |
Trends in Hepatic Injury Associated with Unintentional Overdose of Paracetamol (Acetaminophen) in Products with and without Opioid
|
Bond, G. Randall
|
|
2012
|
|
2 |
p. 149-157
|
artikel
|
| 165 |
Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies
|
Tang, Huilin
|
|
2017
|
|
2 |
p. 161-169
|
artikel
|
| 166 |
Use of Contemporary Antidepressants during Breastfeeding
|
Gentile, Salvatore
|
|
2007
|
|
2 |
p. 107-121
|
artikel
|
| 167 |
Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer
|
Rouette, Julie
|
|
|
|
2 |
p. 245-254
|
artikel
|
| 168 |
Use of Identical INN “Imiglucerase” for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database
|
Tsang, So-Fai
|
|
|
|
2 |
p. 127-136
|
artikel
|
| 169 |
WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems
|
Pal, Shanthi N.
|
|
2013
|
|
2 |
p. 75-81
|
artikel
|
| 170 |
Wonder Vigilance
|
Edwards, I. Ralph
|
|
2010
|
|
2 |
p. 83-86
|
artikel
|
Tijdschrift beschrijving